|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4178 | |
| A61K 31/194 | |||
| A61K 31/198 | |||
| A61K 45/06 | |||
| A61K 31/395 | |||
| A61P 1/16 | |||
| A61P 1/04 | |||
| A61P 29/00 |
| (11) | Patento numeris | 3256124 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15882259.3 |
| Europos patento paraiškos padavimo data | 2015-09-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-12-20 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/051467 |
| Data | 2015-09-22 |
| (87) | Numeris | WO 2016/130179 |
| Data | 2016-08-18 |
| (30) | Numeris | Data | Šalis |
| 201562114304 P | 2015-02-10 | US |
| (72) |
LEFEBVRE, Eric, US
|
| (73) |
Tobira Therapeutics, Inc.,
701 Gateway Boulevard, Suite 300, South San Francisco CA 94080,
US
|
| (54) | COMPOSITION COMPRISING CENICRIVIROC AND FUMARIC ACID FOR USE IN THE TREATMENT OF ACUTE LIVER INJURY OR PERITONITIS |
| COMPOSITION COMPRISING CENICRIVIROC AND FUMARIC ACID FOR USE IN THE TREATMENT OF ACUTE LIVER INJURY OR PERITONITIS |